# Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels.

> **NCT05071404** · — · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 17 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05071404
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05071404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05071404, "Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05071404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*